Cognitive functions in classic phenylketonuria and mild hyperphenyl-alaninaemia:: experience in a paediatric population

被引:70
作者
Gassió, R
Artuch, R
Vilaseca, MA
Fusté, E
Boix, C
Sans, A
Campistol, J
机构
[1] Univ Barcelona, Hosp St Joan Deu, Dept Neuropediat, Barcelona 08950, Spain
[2] Univ Barcelona, Hosp St Joan Deu, Dept Biochem, Barcelona 08950, Spain
[3] Univ Barcelona, Hosp St Joan Deu, Dept Psychol, Barcelona 08950, Spain
关键词
D O I
10.1017/S0012162205000861
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A study of 37 individuals with phenylketonuria (PKU; 17 females and 20 males, mean age 9y 9mo (standard deviation [SD] 5y 3mo), range 2y 8mo to 19y 4mo; and 35 individuals with hyperphenylalaninaemia (HPA; 20 females, 15 males, mean age 7y 10mo [SD 3y 2mo], range 2y 8mo to 17y 3mo) compared with 29 healthy controls (14 females and 15 males, mean age 9y 8mo [SD 4y 9mo], range 2y 6mo to 18y 10mo) was performed. The aim was to assess cognitive function in persons with HPA and to investigate the relation between cognitive function in PKU and the metabolic control of patients. A wide variety of neuropsychological tests was employed. Those with PKU showed lower values in intelligence and in visuo-spatial, fine motor, executive, and attention functions when compared with a control population. Plasma phenylalanine values from the first 6 years of life were negatively associated with intelligence and other cognitive functions. Executive function scores were significantly lower when comparing HPA patients with the control group. It was concluded that individuals with PKU under dietary treatment may present slightly decreased cognitive function scores when compared with control individuals, while those with HPA have scores mostly similar to those of controls, except for executive function tests. Good metabolic control of PKU seems necessary to prevent cognitive function impairments, especially during the first 6 years of life.
引用
收藏
页码:443 / 448
页数:6
相关论文
共 38 条
[1]  
Anderson PJ, 2004, DEV MED CHILD NEUROL, V46, P230, DOI [10.1017/S001212204000386, 10.1017/S0012162204000386]
[2]   Factors affecting cognitive, motor, behavioral and executive functioning in children with phenylketonuria [J].
Arnold, GL ;
Kramer, BM ;
Kirby, RS ;
Plumeau, PB ;
Blakely, EM ;
Cregan, LSS ;
Davidson, PW .
ACTA PAEDIATRICA, 1998, 87 (05) :565-570
[3]   MORPHOLOGIC AND HISTOANATOMIC OBSERVATIONS OF THE BRAIN IN UNTREATED HUMAN PHENYLKETONURIA [J].
BAUMAN, ML ;
KEMPER, TL .
ACTA NEUROPATHOLOGICA, 1982, 58 (01) :55-63
[4]   Development of intelligence in early treated phenylketonuria [J].
Burgard, P .
EUROPEAN JOURNAL OF PEDIATRICS, 2000, 159 (Suppl 2) :S74-S79
[5]  
Conners C. K., 1995, CPT CONNERS CONTINUO
[6]  
COSTELLO PM, 1994, EUR J PEDIATR, V153, P260
[7]  
Diamond A, 1997, MONOGR SOC RES CHILD, V62, P1
[8]  
Dyer CA, 1999, MENT RETARD DEV D R, V5, P104, DOI 10.1002/(SICI)1098-2779(1999)5:2<104::AID-MRDD2>3.0.CO
[9]  
2-7
[10]   Phenylketonuria: No specific frontal lobe-dependent neuropsychological deficits of early-treated patients in comparison with diabetics [J].
Feldmann, R ;
Denecke, J ;
Pietsch, M ;
Grenzebach, M ;
Weglage, J .
PEDIATRIC RESEARCH, 2002, 51 (06) :761-765